12:00 AM
Nov 05, 2012
 |  BC Week In Review  |  Company News  |  Deals

AquaBounty, Intrexon deal

Synthetic biology company Intrexon will acquire a 48% stake in AquaBounty from Linnaeus Capital Partners and its Tethys Ocean B.V. affiliate followed by a tender offer to acquire the rest of the...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >